Kamada KMDA
NASDAQ KMDA
$8.21 -0.08 (-0.97%)
As of: Sep 9, 2026 · 3:59 PM EDT

Kamada (KMDA) Sales of Property, Plant and Equipment (2013 - 2025)

Analysis

Kamada (KMDA) Sales of Property, Plant and Equipment (2013 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Sales of Property, Plant and Equipment (Qtr)
1 Amgen 211.73 Bn 197.74 Bn 7.24 Bn -
2 Gilead Sciences 180.92 Bn 177.74 Bn 6.22 Bn -
3 Vertex Pharmaceuticals 132.16 Bn 124.30 Bn 2.84 Bn -
4 Regeneron Pharmaceuticals 82.89 Bn 74.90 Bn 3.93 Bn -
5 Argenx Se 61.41 Bn 56.23 Bn 1.37 Bn -
6 Moderna 53.99 Bn 48.85 Bn 52.00 Mn -
7 Alnylam Pharmaceuticals 34.48 Bn 31.18 Bn 992.69 Mn -
8 Biogen 31.15 Bn 29.86 Bn 1.96 Bn -
9 Roivant Sciences 30.05 Bn 30.05 Bn 1.16 Mn -
10 Kamada 473.57 Mn 403.43 Mn 22.47 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2025 8,000.00
Jun 30, 2024 1,000.00
Dec 31, 2023 1,000.00
Jun 30, 2023 -18,000.00
Mar 31, 2023 24,000.00
Sep 30, 2020 1,000.00
Jun 30, 2020 6,000.00
Jun 30, 2019 3,000.00
Mar 31, 2019 6,000.00
Dec 31, 2018 15,000.00
Jun 30, 2018 4,000.00
Mar 31, 2018 11,000.00
Dec 31, 2017 3,000.00
Sep 30, 2017 57,000.00
Jun 30, 2017 53,000.00
Dec 31, 2016 1,000.00
Sep 30, 2016 41,000.00
Jun 30, 2016 21,000.00
Mar 31, 2016 21,000.00
Sep 30, 2013 3,000.00